{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:29:58Z","timestamp":1793996998893,"version":"4.8.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8102","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,2,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    HIV cure is exceptionally rare, with only six cases documented among the estimated 88\u2009million individuals who have acquired HIV since the onset of the epidemic\n                    <jats:sup>1\u20136<\/jats:sup>\n                    . Successful cures, including that of\u00a0the pioneering individual known as the Berlin patient, are limited to those who received allogeneic stem cell transplants (allo-SCTs) for haematological cancers. HIV resistance from stem cell donors with the rare homozygous CCR5\u039432 mutation was long considered the main mechanism for HIV remission without antiretroviral therapy. However, recent reports have highlighted CCR5-independent mechanisms as important contributors to HIV cure\n                    <jats:sup>6\u20138<\/jats:sup>\n                    . Here we provide new evidence for this conceptual shift, whereby long, treatment-free HIV remission was achieved after allo-SCT with functionally active CCR5. A man with heterozygous CCR5 wild-type\/\u039432 living with HIV received allo-SCT from a HLA-matched unrelated heterozygous CCR5 wild-type\/\u039432 donor as treatment for acute myeloid leukaemia. Three years after allo-SCT, the patient discontinued antiretroviral therapy. So far, HIV remission has been sustained for more than 6\u2009years with undetectable plasma HIV RNA. Reservoir analysis revealed intact proviral HIV before transplantation, but no replication-competent virus in blood or intestinal tissues after allo-SCT. Declining or absent HIV-specific antibody and T\u2009cell responses support the absence of viral activity. High antibody-dependent cellular cytotoxicity activity at the time of transplantation may have contributed to HIV reservoir clearance. These results demonstrate that CCR5\u039432-mediated HIV resistance is not essential for durable remission, which underscores the importance of effective viral reservoir reductions in HIV cure strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-09893-0","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:02:09Z","timestamp":1764604929000},"page":"701-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sustained HIV-1 remission after heterozygous CCR5\u039432 stem cell transplantation"],"prefix":"10.1038","volume":"650","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-8128","authenticated-orcid":false,"given":"Christian","family":"Gaebler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Kor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Allers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Meixenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Trenkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqin","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Arentowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Odidika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Grahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8354-9943","authenticated-orcid":false,"given":"Rachel","family":"Scheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2869-1564","authenticated-orcid":false,"given":"Naomi","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Pardons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Igbokwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3605-0136","authenticated-orcid":false,"given":"Victor","family":"Corman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4843-2876","authenticated-orcid":false,"given":"Thomas","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u00fcstan","family":"S\u00fcr\u00fcc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Pru\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6360-4192","authenticated-orcid":false,"given":"Christian G.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-2945","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-1792","authenticated-orcid":false,"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-9947","authenticated-orcid":false,"given":"Leif E.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-5510","authenticated-orcid":false,"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-0207","authenticated-orcid":false,"given":"Livius","family":"Penter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0725-7138","authenticated-orcid":false,"given":"Henning","family":"Gruell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-9538","authenticated-orcid":false,"given":"Daniel B.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3375-6800","authenticated-orcid":false,"given":"Philipp","family":"Schommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1446-3474","authenticated-orcid":false,"given":"Angelique","family":"Hoelzemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-9553","authenticated-orcid":false,"given":"Martin","family":"Obermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor W.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-802X","authenticated-orcid":false,"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"9893_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G H\u00fctter","year":"2009","unstructured":"H\u00fctter, G. et al. Long-term control of HIV by CCR5 delta32\/delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692\u2013698 (2009).","journal-title":"N. Engl. J. Med."},{"key":"9893_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","volume":"568","author":"RK Gupta","year":"2019","unstructured":"Gupta, R. K. et al. HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation. Nature 568, 244\u2013248 (2019).","journal-title":"Nature"},{"key":"9893_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","volume":"29","author":"B-EO Jensen","year":"2023","unstructured":"Jensen, B.-E. O. et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation. Nat. Med. 29, 583\u2013587 (2023).","journal-title":"Nat. Med."},{"key":"9893_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","volume":"186","author":"J Hsu","year":"2023","unstructured":"Hsu, J. et al. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant. Cell 186, 1115\u20131126 (2023).","journal-title":"Cell"},{"key":"9893_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMc2312556","volume":"390","author":"JK Dickter","year":"2024","unstructured":"Dickter, J. K. et al. HIV-1 remission after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 390, 669\u2013671 (2024).","journal-title":"N. Engl. J. Med."},{"key":"9893_CR6","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1038\/s41591-024-03277-z","volume":"30","author":"A S\u00e1ez-Ciri\u00f3n","year":"2024","unstructured":"S\u00e1ez-Ciri\u00f3n, A. et al. Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells. Nat. Med. 30, 3544\u20133554 (2024).","journal-title":"Nat. Med."},{"key":"9893_CR7","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1016\/S2352-3018(24)00090-0","volume":"11","author":"M Salgado","year":"2024","unstructured":"Salgado, M. et al. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study. Lancet HIV 11, e389\u2013e405 (2024).","journal-title":"Lancet HIV"},{"key":"9893_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.immuni.2023.04.019","volume":"56","author":"HL Wu","year":"2023","unstructured":"Wu, H. L. et al. Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques. Immunity 56, 1649\u20131663 (2023).","journal-title":"Immunity"},{"key":"9893_CR9","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/infdis\/jiaa270","volume":"222","author":"MC Sneller","year":"2020","unstructured":"Sneller, M. C. et al. Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy. J. Infect. Dis. 222, 1655\u20131659 (2020).","journal-title":"J. Infect. Dis."},{"key":"9893_CR10","unstructured":"UNAIDS. 2024 global AIDS update \u2013 the urgency of now: AIDS at a crossroads. UNAIDS https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024 (2024)."},{"key":"9893_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41579-023-00914-1","volume":"21","author":"RJ Landovitz","year":"2023","unstructured":"Landovitz, R. J., Scott, H. & Deeks, S. G. Prevention, treatment and cure of HIV infection. Nat. Rev. Microbiol. 21, 657\u2013670 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"9893_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/M14-1027","volume":"161","author":"tj henrich","year":"2014","unstructured":"henrich, t. j. et al. Antiretroviral-free HIV-1 remission and viral rebound following allogeneic stem cell transplantation: a report of two cases. Ann. Intern. Med. 161, 319\u2013327 (2014).","journal-title":"Ann. Intern. Med."},{"key":"9893_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002461","volume":"14","author":"NW Cummins","year":"2017","unstructured":"Cummins, N. W. et al. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: a case study. PLoS Med. 14, e1002461 (2017).","journal-title":"PLoS Med."},{"key":"9893_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"The INSIGHT START Study Group","year":"2015","unstructured":"The INSIGHT START Study Group Initiation of antiretroviral therapy in early asymptomatic HIV infection. N. Engl. J. Med. 373, 795\u2013807 (2015).","journal-title":"N. Engl. J. Med."},{"key":"9893_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41409-023-01980-y","volume":"58","author":"A Nagler","year":"2023","unstructured":"Nagler, A. et al. Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP\/EBMT. Bone Marrow Transplant. 58, 791\u2013800 (2023).","journal-title":"Bone Marrow Transplant."},{"key":"9893_CR16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.7326\/0003-4819-127-10-199711150-00004","volume":"127","author":"A-M De Roda Husman","year":"1997","unstructured":"De Roda Husman, A.-M. Association between CCR5 genotype and the clinical course of HIV-1 Infection. Ann. Intern. Med. 127, 882 (1997).","journal-title":"Ann. Intern. Med."},{"key":"9893_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2017-07-798751","volume":"131","author":"B Oran","year":"2018","unstructured":"Oran, B. et al. Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion. Blood 131, 1248\u20131257 (2018).","journal-title":"Blood"},{"key":"9893_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41587-024-02348-3","volume":"43","author":"N Cieri","year":"2025","unstructured":"Cieri, N. et al. Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation. Nat. Biotechnol. 43, 971\u2013982 (2025).","journal-title":"Nat. Biotechnol."},{"key":"9893_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/cid\/ciaa748","volume":"72","author":"DD Murray","year":"2021","unstructured":"Murray, D. D. et al. Altered immune reconstitution in allogeneic stem cell transplant recipients with human immunodeficiency virus (HIV). Clin. Infect. Dis. 72, 1141\u20131146 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"9893_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcv.2018.07.008","volume":"106","author":"V Mortier","year":"2018","unstructured":"Mortier, V. et al. Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART. J. Clin. Virol. 106, 58\u201363 (2018).","journal-title":"J. Clin. Virol."},{"key":"9893_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner, K. M. et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566, 120\u2013125 (2019).","journal-title":"Nature"},{"key":"9893_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymeth.2021.05.006","volume":"201","author":"W van Snippenberg","year":"2022","unstructured":"van Snippenberg, W. et al. Triplex digital PCR assays for the quantification of intact proviral HIV-1 DNA. Methods 201, 41\u201348 (2022).","journal-title":"Methods"},{"key":"9893_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/infdis\/jiq023","volume":"203","author":"G Catano","year":"2011","unstructured":"Catano, G. et al. Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates. J. Infect. Dis. 203, 263\u2013272 (2011).","journal-title":"J. Infect. Dis."},{"key":"9893_CR24","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1126\/science.282.5395.1907","volume":"282","author":"MP Martin","year":"1998","unstructured":"Martin, M. P. et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282, 1907\u20131911 (1998).","journal-title":"Science"},{"key":"9893_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000332002","volume":"55","author":"A Thielen","year":"2012","unstructured":"Thielen, A. & Lengauer, T. Geno2pheno[454]: a web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data. Intervirology 55, 113\u2013117 (2012).","journal-title":"Intervirology"},{"key":"9893_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.182660","volume":"9","author":"N S\u00e1nchez-Gaona","year":"2024","unstructured":"S\u00e1nchez-Gaona, N. et al. NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control. JCI Insight 9, e182660 (2024).","journal-title":"JCI Insight"},{"key":"9893_CR27","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","volume":"116","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m, N. K. et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116, 3853\u20133864 (2010).","journal-title":"Blood"},{"key":"9893_CR28","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.4049\/jimmunol.1401990","volume":"195","author":"A Horowitz","year":"2015","unstructured":"Horowitz, A. et al. Regulation of adaptive NK cells and CD8 T cells by HLA-C correlates with allogeneic hematopoietic cell transplantation and with cytomegalovirus reactivation. J. Immunol. 195, 4524\u20134536 (2015).","journal-title":"J. Immunol."},{"key":"9893_CR29","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3389\/fimmu.2017.01496","volume":"8","author":"A H\u00f6lzemer","year":"2017","unstructured":"H\u00f6lzemer, A., Garcia-Beltran, W. F. & Altfeld, M. Natural killer cell interactions with classical and non-classical human leukocyte antigen class I in HIV-1 infection. Front. Immunol. 8, 1496 (2017).","journal-title":"Front. Immunol."},{"key":"9893_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng934","volume":"31","author":"MP Martin","year":"2002","unstructured":"Martin, M. P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31, 429\u2013434 (2002).","journal-title":"Nat. Genet."},{"key":"9893_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ng2035","volume":"39","author":"MP Martin","year":"2007","unstructured":"Martin, M. P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733\u2013740 (2007).","journal-title":"Nat. Genet."},{"key":"9893_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100670","volume":"6","author":"A Essat","year":"2025","unstructured":"Essat, A. et al. A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI\/PRIMO. Med 6, 100670 (2025).","journal-title":"Med"},{"key":"9893_CR33","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.4049\/jimmunol.1900423","volume":"203","author":"AR Manser","year":"2019","unstructured":"Manser, A. R. et al. KIR polymorphism modulates the size of the adaptive NK cell pool in human cytomegalovirus\u2013infected individuals. J. Immunol. 203, 2301\u20132309 (2019).","journal-title":"J. Immunol."},{"key":"9893_CR34","first-page":"343","volume":"30","author":"JZ Li","year":"2016","unstructured":"Li, J. Z. et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS 30, 343 (2016).","journal-title":"AIDS"},{"key":"9893_CR35","doi-asserted-by":"publisher","first-page":"20201015","DOI":"10.1098\/rsif.2020.1015","volume":"18","author":"JM Conway","year":"2021","unstructured":"Conway, J. M., Meily, P., Li, J. Z. & Perelson, A. S. Unified model of short- and long-term HIV viral rebound for clinical trial planning. J. R. Soc. Interface 18, 20201015 (2021).","journal-title":"J. R. Soc. Interface"},{"key":"9893_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005535","volume":"12","author":"AL Hill","year":"2016","unstructured":"Hill, A. L. et al. Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV. PLoS Pathog. 12, e1005535 (2016).","journal-title":"PLoS Pathog."},{"key":"9893_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005000","volume":"11","author":"M Pinkevych","year":"2015","unstructured":"Pinkevych, M. et al. HIV reactivation from latency after treatment interruption occurs on average every 5-8 days\u2014implications for HIV remission. PLoS Pathog. 11, e1005000 (2015).","journal-title":"PLoS Pathog."},{"key":"9893_CR38","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1371\/journal.pbio.0030339","volume":"3","author":"J Novembre","year":"2005","unstructured":"Novembre, J., Galvani, A. P. & Slatkin, M. The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol. 3, e339 (2005).","journal-title":"PLoS Biol."},{"key":"9893_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013003","volume":"21","author":"DB Reeves","year":"2025","unstructured":"Reeves, D. B. et al. Intact HIV DNA decays in children with and without complete viral load suppression. PLoS Pathog. 21, e1013003 (2025).","journal-title":"PLoS Pathog."},{"key":"9893_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.96617.4","volume":"13","author":"K Reddy","year":"2025","unstructured":"Reddy, K. et al. Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 clade C infection. eLife 13, RP96617 (2025).","journal-title":"eLife"},{"key":"9893_CR41","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1128\/AAC.02496-13","volume":"58","author":"C Gavegnano","year":"2014","unstructured":"Gavegnano, C. et al. Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrob. Agents Chemother. 58, 1977\u20131986 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9893_CR42","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41590-022-01327-7","volume":"23","author":"T R\u00fcckert","year":"2022","unstructured":"R\u00fcckert, T., Lareau, C. A., Mashreghi, M.-F., Ludwig, L. S. & Romagnani, C. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. Nat. Immunol. 23, 1551\u20131563 (2022).","journal-title":"Nat. Immunol."},{"key":"9893_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/jleuko\/qiac007","volume":"113","author":"RR Anderko","year":"2023","unstructured":"Anderko, R. R. & Mailliard, R. B. Mapping the interplay between NK cells and HIV: therapeutic implications. J. Leukoc. Biol. 113, 109 (2023).","journal-title":"J. Leukoc. Biol."},{"key":"9893_CR44","doi-asserted-by":"publisher","first-page":"102150","DOI":"10.1016\/j.xcrm.2025.102150","volume":"6","author":"B Bone","year":"2025","unstructured":"Bone, B. et al. Distinct viral reservoirs and immune signatures in individuals on long-term antiretroviral therapy with perinatally acquired HIV-1. Cell Rep. Med. 6, 102150 (2025).","journal-title":"Cell Rep. Med."},{"key":"9893_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10844","volume":"7","author":"T Bruel","year":"2016","unstructured":"Bruel, T. et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nat. Commun. 7, 10844 (2016).","journal-title":"Nat. Commun."},{"key":"9893_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41590-023-01741-5","volume":"25","author":"NL Board","year":"2024","unstructured":"Board, N. L. et al. Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. Nat. Immunol. 25, 462\u2013470 (2024).","journal-title":"Nat. Immunol."},{"key":"9893_CR47","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/infdis\/jit086","volume":"207","author":"TJ Henrich","year":"2013","unstructured":"Henrich, T. J. et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J. Infect. Dis. 207, 1694\u20131702 (2013).","journal-title":"J. Infect. Dis."},{"key":"9893_CR48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7326\/0003-4819-135-9-200111060-00008","volume":"135","author":"JPA Ioannidis","year":"2001","unstructured":"Ioannidis, J. P. A. et al. Effects of CCR5-\u0394 32, CCR2-64I, and SDF-1 3\u2032A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann. Intern. Med. 135, 782\u2013795 (2001).","journal-title":"Ann. Intern. Med."},{"key":"9893_CR49","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/molbev\/msq326","volume":"28","author":"D Edo-Matas","year":"2011","unstructured":"Edo-Matas, D. et al. Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models. Mol. Biol. Evol. 28, 1605\u20131616 (2011).","journal-title":"Mol. Biol. Evol."},{"key":"9893_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28130-0","volume":"13","author":"M Claireaux","year":"2022","unstructured":"Claireaux, M. et al. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry. Nat. Commun. 13, 521 (2022).","journal-title":"Nat. Commun."},{"key":"9893_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.09.007","volume":"6","author":"\u00c1 Bay\u00f3n-Gil","year":"2024","unstructured":"Bay\u00f3n-Gil, \u00c1 et al. Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors. Med 6, 100518 (2024).","journal-title":"Med"},{"key":"9893_CR52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181576","volume":"134","author":"P Tebas","year":"2024","unstructured":"Tebas, P. et al. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. J. Clin. Invest. 134, e181576 (2024).","journal-title":"J. Clin. Invest."},{"key":"9893_CR53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/infdis\/jiv504","volume":"213","author":"TJ Henrich","year":"2016","unstructured":"Henrich, T. J. et al. CCR5-\u039432 heterozygosity, HIV-1 reservoir size, and lymphocyte activation in individuals receiving long-term suppressive antiretroviral therapy. J. Infect. Dis. 213, 766\u2013770 (2016).","journal-title":"J. Infect. Dis."},{"key":"9893_CR54","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cmi.2016.12.020","volume":"23","author":"M Mart\u00ednez-Bonet","year":"2017","unstructured":"Mart\u00ednez-Bonet, M. et al. Relationship between CCR5(WT\/\u039432) heterozygosity and HIV-1 reservoir size in adolescents and young adults with perinatally acquired HIV-1 infection. Clin. Microbiol. Infect. 23, 318\u2013324 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"9893_CR55","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/infdis\/jiu338","volume":"210","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Decreased HIV type 1 transcription in CCR5-\u039432 heterozygotes during suppressive antiretroviral therapy. J. Infect. Dis. 210, 1838\u20131843 (2014).","journal-title":"J. Infect. Dis."},{"key":"9893_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2015.06.007","volume":"14","author":"K Allers","year":"2015","unstructured":"Allers, K. & Schneider, T. CCR5\u039432 mutation and HIV infection: basis for curative HIV therapy. Curr. Opin. Virol. 14, 24\u201329 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"9893_CR57","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","volume":"117","author":"K Allers","year":"2011","unstructured":"Allers, K. et al. Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation. Blood 117, 2791\u20132799 (2011).","journal-title":"Blood"},{"key":"9893_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109330","volume":"27","author":"M Lebedin","year":"2024","unstructured":"Lebedin, M. et al. Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses. iScience 27, 109330 (2024).","journal-title":"iScience"},{"key":"9893_CR59","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin, R. et al. A universal SNP and small-indel variant caller using deep neural networks. Nat. Biotechnol. 36, 983\u2013987 (2018).","journal-title":"Nat. Biotechnol."},{"key":"9893_CR60","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"9893_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"9893_CR62","doi-asserted-by":"crossref","unstructured":"Shacklett, B. L., Critchfield, J. W. & Lemongello, D. in HIV Protocols (eds Prasad, V. R. & Kalpana, G. V.) 347\u2013356 (Humana Press, 2009).","DOI":"10.1007\/978-1-59745-170-3_23"},{"key":"9893_CR63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virol.2008.05.030","volume":"379","author":"JJ Yu","year":"2008","unstructured":"Yu, J. J. et al. A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology 379, 78\u201386 (2008).","journal-title":"Virology"},{"key":"9893_CR64","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1084\/jem.20190896","volume":"216","author":"C Gaebler","year":"2019","unstructured":"Gaebler, C. et al. Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir. J. Exp. Med. 216, 2253\u20132264 (2019).","journal-title":"J. Exp. Med."},{"key":"9893_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv123","volume":"2","author":"DIS Rosenbloom","year":"2015","unstructured":"Rosenbloom, D. I. S. et al. Designing and interpreting limiting dilution assays: general principles and applications to the latent reservoir for human immunodeficiency virus-1. Open Forum Infect. Dis. 2, ofv123 (2015).","journal-title":"Open Forum Infect. Dis."},{"key":"9893_CR66","doi-asserted-by":"publisher","first-page":"12004","DOI":"10.1073\/pnas.96.21.12004","volume":"96","author":"E Gonzalez","year":"1999","unstructured":"Gonzalez, E. et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc. Natl Acad. Sci. USA 96, 12004\u201312009 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9893_CR67","doi-asserted-by":"publisher","first-page":"e2747","DOI":"10.1371\/journal.pone.0002747","volume":"3","author":"D-Y Oh","year":"2008","unstructured":"Oh, D.-Y. et al. CCR5\u039432 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5\u039432 homozygous individual. PLoS ONE 3, e2747 (2008).","journal-title":"PLoS ONE"},{"key":"9893_CR68","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nbt1371","volume":"25","author":"T Lengauer","year":"2007","unstructured":"Lengauer, T., Sander, O., Sierra, S., Thielen, A. & Kaiser, R. Bioinformatics prediction of HIV coreceptor usage. Nat. Biotechnol. 25, 1407\u20131410 (2007).","journal-title":"Nat. Biotechnol."},{"key":"9893_CR69","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1128\/JCM.01516-12","volume":"50","author":"A Gall","year":"2012","unstructured":"Gall, A. et al. Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes. J. Clin. Microbiol. 50, 3838\u20133844 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"9893_CR70","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.virol.2011.11.003","volume":"422","author":"BE Sanders-Beer","year":"2012","unstructured":"Sanders-Beer, B. E. et al. Characterization of a monoclonal anti-capsid antibody that cross-reacts with three major primate lentivirus lineages. Virology 422, 402\u2013412 (2012).","journal-title":"Virology"},{"key":"9893_CR71","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nprot.2008.108","volume":"3","author":"MS Malnati","year":"2008","unstructured":"Malnati, M. S. et al. A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat. Protoc. 3, 1240\u20131248 (2008).","journal-title":"Nat. Protoc."},{"key":"9893_CR72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/QAI.0000000000000097","volume":"66","author":"K Allers","year":"2014","unstructured":"Allers, K. et al. Effect of age on the CD4+ T-cell impairment in HIV-infected persons without and with cART. J. Acquir. Immune Defic. Syndr. 66, 7\u201315 (2014).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"9893_CR73","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/cir493","volume":"53","author":"LC Swenson","year":"2011","unstructured":"Swenson, L. C. et al. Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc. Clin. Infect. Dis. 53, 732\u2013742 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"9893_CR74","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/nar\/gkh340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792 (2004).","journal-title":"Nucleic Acids Res."},{"key":"9893_CR75","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/2041-210X.13512","volume":"12","author":"D Edler","year":"2021","unstructured":"Edler, D., Klein, J., Antonelli, A. & Silvestro, D. raxmlGUI 2.0: a graphical interface and toolkit for phylogenetic analyses using RAxML. Methods Ecol. Evol. 12, 373\u2013377 (2021).","journal-title":"Methods Ecol. Evol."},{"key":"9893_CR76","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","volume":"561","author":"P Mendoza","year":"2018","unstructured":"Mendoza, P. et al. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature 561, 479\u2013484 (2018).","journal-title":"Nature"},{"key":"9893_CR77","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.02660-07","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","unstructured":"Salazar-Gonzalez, J. F. et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82, 3952 (2008).","journal-title":"J. Virol."},{"key":"9893_CR78","first-page":"131","volume":"0","author":"M Sarzotti-Kelsoe","year":"2013","unstructured":"Sarzotti-Kelsoe, M. et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 0, 131 (2013).","journal-title":"J. Immunol. Methods"},{"key":"9893_CR79","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.3389\/fimmu.2018.02843","volume":"9","author":"I Wagner","year":"2018","unstructured":"Wagner, I. et al. Allele-level KIR genotyping of more than a million samples: workflow, algorithm, and observations. Front. Immunol. 9, 2843 (2018).","journal-title":"Front. Immunol."},{"key":"9893_CR80","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/tan.15126","volume":"102","author":"SJ Mack","year":"2023","unstructured":"Mack, S. J. et al. Genotype List String 1.1: extending the genotype list string grammar for describing HLA and killer-cell immunoglobulin-like receptor genotypes. HLA 102, 206\u2013212 (2023).","journal-title":"HLA"},{"key":"9893_CR81","doi-asserted-by":"publisher","unstructured":"Borggrewe, M., Flosbach, M., Group, H. I. T. S., Bonn, S. & Bunders, M. J. Seumetry: a versatile and comprehensive R toolkit to accelerate high-dimensional flow and mass cytometry data analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.23.604747 (2024).","DOI":"10.1101\/2024.07.23.604747"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09893-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09893-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09893-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:03:33Z","timestamp":1771423413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09893-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":81,"journal-issue":{"issue":"8102","published-print":{"date-parts":[[2026,2,19]]}},"alternative-id":["9893"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09893-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}